Kaufmann, Christoph C. http://orcid.org/0000-0002-4710-0522
Ahmed, Amro
Kassem, Mona
Freynhofer, Matthias K.
Jäger, Bernhard
Aicher, Gabriele
Equiluz-Bruck, Susanne
Spiel, Alexander O.
Vafai-Tabrizi, Florian
Gschwantler, Michael
Fasching, Peter
Wojta, Johann
Giannitsis, Evangelos
Huber, Kurt
Funding for this research was provided by:
Bürgermeisterfond der Stadt Wien
Association for the Promotion of Research on Arteriosclerosis, Thrombosis, and Vascular Biology
Ludwig Boltzmann Cluster for Cardiovascular Research
Article History
Received: 25 May 2021
Accepted: 2 November 2021
First Online: 15 November 2021
Declarations
:
: Dr. Huber reports Honoraria for lectures from AstraZeneca, Bayer, Boehringer Ingelheim, B·R·A·H·M·S Thermo Fisher, Daiichi Sankyo, Pfizer, Sanofi and The Medicines Company and has received research funding form AstraZeneca and B·R·A·H·M·S Thermo Fisher. Dr. Giannitsis reports Honoraria for lecturers from Roche Diagnostics, BRAHMS Thermo Fisher Scientific, Bayer Vital GmbH and Mitsubishi Chemical Europe, institutional research grant from Roche Diagnostics and Daiichi Sankyo, consultant for Roche Diagnostics and BRAHMS Thermo Fisher Scientific, outside the submitted work. The other authors do not have any conflicts of interest to disclose.
: Research involving human subjects complied with all relevant national regulations, institutional policies and is in accordance with the tenets of the Helsinki Declaration (as revised in 2013) and has been approved by the local ethics committee of the city of Vienna (EK 20-100-VK).
Free to read: This content has been made available to all.